Hubei Biological Medicine Industrial Technology Institute Co., Ltd. Report issue

Academic/Hospital Phase 1
Founded: Hubei China

Organization Overview

First Clinical Trial
2015
NCT02374684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hubei Biological Medicine Industrial Technology Institute Co., Ltd.

Active Ingredients

Drugs in Phase 1 Trials (2)

hwh340 (1 trial)

methosulide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2